347 related articles for article (PubMed ID: 7659086)
1. Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alpha.
Rodenburg RJ; Teertstra W; Holthuizen PE; Sussenbach JS
Mol Endocrinol; 1995 Apr; 9(4):424-34. PubMed ID: 7659086
[TBL] [Abstract][Full Text] [Related]
2. Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBP alpha and LAP.
Nolten LA; van Schaik FM; Steenbergh PH; Sussenbach JS
Mol Endocrinol; 1994 Dec; 8(12):1636-45. PubMed ID: 7708053
[TBL] [Abstract][Full Text] [Related]
3. A functional Sp1 binding site is essential for the activity of the adult liver-specific human insulin-like growth factor II promoter.
Rodenburg RJ; Holthuizen PE; Sussenbach JS
Mol Endocrinol; 1997 Feb; 11(2):237-50. PubMed ID: 9013771
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites.
Nolten LA; Steenbergh PH; Sussenbach JS
Mol Endocrinol; 1995 Nov; 9(11):1488-99. PubMed ID: 8584026
[TBL] [Abstract][Full Text] [Related]
5. Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1, CCAAT/enhancer-binding protein alpha, liver activator protein, and D-element-binding protein.
van Ooij C; Snyder RC; Paeper BW; Duester G
Mol Cell Biol; 1992 Jul; 12(7):3023-31. PubMed ID: 1620113
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a teleost insulin-like growth factor II (IGF-II) gene: evidence for promoter CCAAT/enhancer-binding protein (C/EBP) sites, and the presence of hepatic C/EBP.
Shamblott MJ; Leung S; Greene MW; Chen TT
Mol Mar Biol Biotechnol; 1998 Sep; 7(3):181-90. PubMed ID: 9701612
[TBL] [Abstract][Full Text] [Related]
7. The liver-specific promoter of the human insulin-like growth factor II gene is activated by CCAAT/enhancer binding protein (C/EBP).
van Dijk MA; Rodenburg RJ; Holthuizen P; Sussenbach JS
Nucleic Acids Res; 1992 Jun; 20(12):3099-104. PubMed ID: 1620607
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein-alpha-dependent transactivation of CYP2C12 in rat hepatocytes.
Tollet P; Lahuna O; Ahlgren R; Mode A; Gustafsson JA
Mol Endocrinol; 1995 Dec; 9(12):1771-81. PubMed ID: 8614413
[TBL] [Abstract][Full Text] [Related]
9. Cytokine regulation of the liver transcription factor hepatocyte nuclear factor-3 beta is mediated by the C/EBP family and interferon regulatory factor 1.
Samadani U; Porcella A; Pani L; Johnson PF; Burch JB; Pine R; Costa RH
Cell Growth Differ; 1995 Jul; 6(7):879-90. PubMed ID: 7547510
[TBL] [Abstract][Full Text] [Related]
10. Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription.
Niehof M; Kubicka S; Zender L; Manns MP; Trautwein C
J Mol Biol; 2001 Jun; 309(4):855-68. PubMed ID: 11399064
[TBL] [Abstract][Full Text] [Related]
11. Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP).
Park EA; Gurney AL; Nizielski SE; Hakimi P; Cao Z; Moorman A; Hanson RW
J Biol Chem; 1993 Jan; 268(1):613-9. PubMed ID: 8093246
[TBL] [Abstract][Full Text] [Related]
12. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences.
Ji C; Chen Y; Centrella M; McCarthy TL
Endocrinology; 1999 Oct; 140(10):4564-72. PubMed ID: 10499512
[TBL] [Abstract][Full Text] [Related]
13. DNA elements and protein factors involved in the transcription of the beta 2-adrenergic receptor gene in rat liver. The negative regulatory role of C/EBP alpha.
Jiang L; Gao B; Kunos G
Biochemistry; 1996 Oct; 35(40):13136-46. PubMed ID: 8855951
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone.
Umayahara Y; Ji C; Centrella M; Rotwein P; McCarthy TL
J Biol Chem; 1997 Dec; 272(50):31793-800. PubMed ID: 9395525
[TBL] [Abstract][Full Text] [Related]
15. SF-1 (steroidogenic factor-1) and C/EBP beta (CCAAT/enhancer binding protein-beta) cooperate to regulate the murine StAR (steroidogenic acute regulatory) promoter.
Reinhart AJ; Williams SC; Clark BJ; Stocco DM
Mol Endocrinol; 1999 May; 13(5):729-41. PubMed ID: 10319323
[TBL] [Abstract][Full Text] [Related]
16. SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells.
Aigueperse C; Val P; Pacot C; Darne C; Lalli E; Sassone-Corsi P; Veyssiere G; Jean C; Martinez A
Mol Endocrinol; 2001 Jan; 15(1):93-111. PubMed ID: 11145742
[TBL] [Abstract][Full Text] [Related]
17. Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter.
Diehl AM; Yang SQ
Hepatology; 1994 Feb; 19(2):447-56. PubMed ID: 8294101
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the major promoters of the human IGF-II gene.
Holthuizen P; Van Dijk MA; Rodenburg RJ; Koonen-Reemst AM; Sussenbach JS
Mol Reprod Dev; 1993 Aug; 35(4):391-3. PubMed ID: 8398117
[TBL] [Abstract][Full Text] [Related]
19. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
20. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
